Lonza | LONN - Operating Expenses

Stock Price
520.60
Daily Change
-1.20 -0.23%
Monthly
-2.80%
Yearly
-15.07%
Q1 Forecast
512.24

Lonza reported CHF3.09B in Operating Expenses for its fiscal semester ending in December of 2024.





Operating Expenses Change Date
Akzo Nobel EUR 2.25B 73M Sep/2025
Alcon AG USD 2.28B 67M Sep/2025
Almirall EUR 517.43M 43.18M Jun/2025
AstraZeneca USD 16.69B 5.74B Sep/2025
BASF EUR 13.84B 1.11B Sep/2025
Bayer EUR 10.2B 523M Sep/2025
Beiersdorf EUR 4.37B 143M Jun/2025
Covestro EUR -2.22B 5.55B Sep/2025
Demant DKK 9.39B 392M Jun/2025
Fresenius EUR 4.91B 110M Sep/2025
Fresenius Medical Care EUR 4.43B 73.91M Sep/2025
Geberit CHF 582.6M 8.4M Sep/2025
Genmab DKK 565M 38M Jun/2025
Givaudan CHF 1.5B 1.35B Jun/2024
GlaxoSmithKline GBP 5.76B 203M Sep/2025
GN Store Nord DKK 3.62B 81M Sep/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Johnson Matthey GBP 5.21B 600M Dec/2025
Merck EUR 4.11B 117M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Philips EUR 3.97B 123M Sep/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Sika AG CHF 4.88B 158.3M Jun/2025
Smith & Nephew USD 2.52B 84M Dec/2025
Solvay EUR 1.06B 28M Sep/2025
UCB EUR 2.36B 108M Dec/2024